INTEREST HARARE – ZIMBABWE 9Th INTERNATIONAL WORKSHOP on HIV TREATMENT, PATHOGENESIS and PREVENTION RESEARCH in RESOURCE-LIMITED SETTINGS

5 - 8 MAY 2015 INTEREST HARARE – ZIMBABWE 9th INTERNATIONAL WORKSHOP ON HIV TREATMENT, PATHOGENESIS AND PREVENTION RESEARCH IN RESOURCE-LIMITED SETTINGS

EVALUATION REPORT

www.virology-education.com CONTENT

Executive Summary...... 3 Introduction...... 4 Background...... 4 Format...... 4 Unique Meeting Features...... 4 Target Audience...... 5 Meeting Objectives...... 5 Learning Objectives...... 5 Acknowledgements...... 6 Organizing Committee...... 7 Local Organizing Committee...... 9 Scientific Committee ...... 10 Participants’ Feedback...... 11 Lectures...... 11 Take home messages...... 19 Meeting objectives...... 20 Impact...... 20 Abstracts ...... 20 Organization...... 21 General event experience...... 21 Meeting demographics...... 22 Number of Registrants...... 22 Professional Background...... 22 Participants’ Comments...... 23 Suggestion for improvement ...... 23 Challenges facing daily practice...... 23 Final remarks...... 23 Conclusion...... 24 List of Participants...... 25

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 2 EXECUTIVE SUMMARY

The INTEREST Workshop initiative was launched in 2007 and spearheaded by Professors Joep M.A. Lange (Amsterdam Institute for Global Health and Development (AIGHD), Academic Medical Center, Department of Global Health / University of Amsterdam) and Charles A.B. Boucher (Erasmus Medical Center Rotterdam, University of Rotterdam). Together with a prominent group of international experts in the field of HIV/AIDS, an annual international meeting in Africa has been developed. During these meetings, experts in the field of HIV prevention and treatment share their knowledge and views on a variety of HIV related topics. Due to the tragic accident of the MALAYSIAN MH17 flight in July 2014, Professor Joep M.A. Lange died. Professor Catherine Hankins (AIGHD), has successfully taken up the task as Scientific Chair from Professor Joep Lange in the continuation of this yearly African event.

The workshop focuses on issues of particular relevance for the African continent and gives opportunity to young researchers to present their data. The workshop atmosphere stimulates and facilitates discussion and interaction between participants.

This year’s workshop, opened by Dr David Parirenyatwa, Minister of Health and Child Care of Zimbabwe, consisted of plenary sessions, roundtable discussions, a debate, satellite symposia, abstract presentations and poster discussions. New this year was the debate, which was very well received by the participants.

Special attention was given to young researchers. In the early morning seminars, prior to the workshop program, well- published world class scientists explained how they got started on a research career, gave advice and answered questions from aspiring junior researchers. Opportunity was given to early career investigators to meet the expert.

The Embassy of The Netherlands in Harare and UNAIDS sponsored a site visit to the research hospital in Chitungwiza in the afternoon after the workshop

One of the conclusions of the evaluation is that almost all respondents will plan to attend the meeting again next year and will recommend the workshop to their colleagues. 81% of the respondents labelled the content of the workshop as excellent, the other 19% as very good.

The number of participants and represented countries of the INTEREST Workshop is increasing each year. This year 473 delegates from 26 countries registered while in 2014: 414 delegates from 23 countries registered for the workshop. The number of clinicians increased from 50% to 60%. See also the following charts:

Professional Background 2015 2014

Marketing person Other 1% Other 20% Student 12% 5% Student 5% Marketing Clinicians 50% persons 2% Clinician Researcher 60% Researchers 22% 23%

Excellent conference! Highly appreciated meeting.

Very informative and educative up to date event.

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 3 INTRODUCTION

This is the evaluation report of the 9th International workshop on HIV Treatment, Pathogenesis and Prevention Research in Resource-Limited Settings, held on 5-8 May 2015 in the Rainbow Towers Hotel in Harare, Zimbabwe.

The Organizing Committee, Scientific Committee and Organizing Secretariat highly value the opinion of the participants in order to further improve the quality of the workshop. Participants are asked to complete four evaluation forms, one form on each day, to share their opinion on several subjects.

BACKGROUND The INTEREST workshop was initiated 9 years ago with the objective

• To function as a platform to discuss how recent insights in HIV may translate into new intervention strategies for areas with limited resources

• To gather experts involved in HIV from different disciplines in an interactive workshop setting

• To provide a platform for presentation of the latest developments in the field

• To translate new data into treatment guidelines

• To stimulate discussion and consensus on best practice

• To give researchers a platform FORMAT This three and a half day international workshop consists of plenary sessions with invited lectures by key opinion leaders, roundtable discussions, a debate, satellite symposia, oral abstract presentations and poster discussions. The setup of the workshop with ample time for Q&A, resulted in a highly interactive workshop.

This year, for the first time early morning sessions were held prior to the workshop program. In these sessions well- published world class scientists explained how they got started on a research career, gave advice and answered questions from aspiring junior researchers. Opportunity was given to early career investigators to meet the expert.

.UNIQUE MEETING FEATURES • The INTEREST workshop is a unique scientific platform where clinicians and researchers from Africa and key persons from other parts of the world are brought together to present and discuss the latest developments in treatment, pathogenesis and prevention research

• The INTEREST meeting offers a unique platform to discuss issues of particular relevance for the African continent. It is referred to as “The African CROI”.

• It provides a forum for high-level exchange of scientific advances that will improve the prevention of HIV infection and the care of people living with HIV in Africa.

• It is a critical element of strengthening the African community and forging new collaborations to advance the African medical research agenda

• The workshop gives young researchers the possibility to present their data and to communicate with colleagues and key persons in the field.

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 4 TARGET AUDIENCE • Clinicians involved in HIV treatment and care

• Researchers

• Medical and PHD students

• Policy makers

MEETING OBJECTIVES • To bring together professionals in the field of infectious diseases and clinical virology in an interactive workshop setting

• To provide a platform for presentation and discussion of the latest developments in the field of antiviral drug development

• To map all current studies and results

• To translate new data to treatment guidelines

• To educate clinicians on how to best implement current and new drugs in clinical practice

LEARNING OBJECTIVES After participating in this activity, the participants will:

• Have improved their knowledge of the most recent results in HIV treatment, pathogenesis and prevention research

• Be able to integrate the latest scientific results into daily clinical care to improve the quality of life of HIV infected individuals

• Be able to recognize the future challenges in screening, monitoring and diagnosis of HIV infected patients

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 5 ACKNOWLEDGEMENTS

Financial support for the 9th INTEREST workshop has been provided by:

PLATINUM LEVEL

GOLD LEVEL

BRONZE LEVEL SUPPORTER LEVEL

OTHER

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 6 ORGANIZING COMMITTEE

CHARLES BOUCHER, MD, PIERRE-MARIE GIRARD, PHD MD, PHD

Erasmus Medical Université Pierre et Center, Rotterdam, the Marie Curie, Paris, Netherlands France

JAMES HAKIM, MBCHB, CATHERINE HANKINS, MMEDSCI, FRCP MD, PHD, FRCPC, CM

University of Zimbabwe, AIGHD Zimbabwe the Netherlands

ELLY KATABIRA, MD, RICHARD KOUP, MD FRCP Vaccine Research Center, Makerere University, NIAID, NIH, USA College of Health Sciences, Uganda

CHEWE LUO, MD, PHD TIMOTHY MASTRO, MD, FACP, DTM&H UNICEF, USA/ University Teaching School, Zambia FHI360, USA

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 7 ORGANIZING COMMITTEE

ANGELA MUSHAVI, HELEN REES, MD, MA, MBCHB, MMED MRCGP

Ministry of Health of WRHI, University of the Zimbabwe, Zimbabwe Witwatersrand, South Africa

ANNA LAURA ROSS, PHD PAPA SALIF SOW, MD, MS

National Agency for AIDS Dakar University Research (ANRS), France Hospital, Senegal, Bill & Melinda Gates Foundation, USA

KENLY SIKWESE

African Community Advisory Board (AFROCAB), Zambia

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 8 LOCAL ORGANIZING COMMITTEE

TAPIWA BWAKURA, MD CLEOPHAS CHIMBETETE, MPH Harare Central and Teaching Hospital, Newlands Clinic, Zimabwe Zimbabwe

INGRID LANDMAN, MD PRECIOUS LUNGA, PHD

HIV Clinicians Society, Econet Wireless, Zimbabwe Zimbabwe

AGNES MAHOMVA, MIKE MBIZVO, MD MBCHB, MPH University of Zimbabwe, Zimbabwe Medial Zimbabwe Association, Zimbabwe

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 9 SCIENTIFIC COMMITTEE

Linda-Gail Bekker, MBChB, FCP, PhD �� Desmond Tutu HIV Foundation, University of Cape Town, South Africa

Elisabeth Bukusi, MBChB, MD, MPH, PhD �� Kenya Medical Research Institute, Nairobi, Kenia

Namwinga Chintu, MD, MMed(Ped), MTrop �� Society for Family Health, Zambia

Serge Paul Eholié, MD, PhD �� Hospital BPV3, Ivory coast

Guido Ferrari, MD �� Duke University Medical Center, USA

Gabriela Gomez, PhD �� Amsterdam Institute for Global Health and Development, the Netherlands

Grace John-Stewart, MD, PhD �� University of Washington, USA

Andrew Kambugu, MBChB, Mmed �� Makerere University College of Health Sciences, Uganda

Saidi Kapiga, MD, MPH, ScD �� Mwanza Intervention Trials Unit, NIMR and LSHTM, Tanzania/UK

Peter Kilmarx, MD, FACP, FIDSA �� CDC Atlanta, USA & Harare, Zimbabwe

Nagalingeshwaran Kumarasamy, MD �� YRG Centre for AIDS Research and Education, India

Catherine Kyobutungi, PhD �� African Population and Health Research Center, Kenya

Mauro Schechter, MD, PhD �� Federal University, Rio de Janeiro, Brazil

Robert Schooley, MD �� University of California, San Diego, USA

Coumba Touré Kane, PharmD, PhD �� CHU Le Dantec, Dakar University, Senegal

Francois Venter, MD �� WRHI, University of the Witwatersrand, South Africa

Robin Wood, MBChB, BMBCh �� Desmond Tutu HIV Foundation, University of Cape Town, SA

Debrework Zewdie, PhD �� World Bank, USA

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 10 PARTICIPANTS’ FEEDBACK

LECTURES TUESDAY 5 MAY Session: Roundtable: Lessons learned from Ebola for HIV and vice versa

Excellent Good Average Fair Poor Responding to an epidemic: Topic is interesting 61% 36% 2% 1% 0% perspective from Sierra Leone and Guinee Content is relevant to my 46% 34% 12% 7% 1% work Peter Kilmarx, Zimbabwe Speakers’ performance 55% 40% 5% 0% 0%

Responding to an epidemic: Excellent Good Average Fair Poor perspective from Liberia Topic is interesting 33% 38% 22% 5% 2% Brian Hunter, Zimbabwe Content is relevant to my 33% 48% 18% 1% 0% work Speakers’ performance 53% 39% 7% 1% 0%

Vaccine and drugs pipeline and Excellent Good Average Fair Poor trials: passive immunization Topic is interesting 53% 39% 7% 1% 0% (convalescent serum) and Content is relevant to my 27% 42% 23% 4% 4% regulatory issues work Peter Kilmarx, Zimbabwe Speakers’ performance 39% 43% 16% 2% 0%

Satellite symposium AbbVie: Managing HIV in resource-limited settings- Growing the momentum

Viral load monitoring in RLS: Excellent Good Average Fair Poor challenges and lessons; a South Topic is interesting 80% 19% 1% 0% 0% African perspective Content is relevant to my 73% 24% 3% 0% 0% Francesca Conradie, South work Africa Speakers’ performance 68% 29% 3% 0% 0%

Acquired drug resistance in Excellent Good Average Fair Poor RLS: the causes, patterns and Topic is interesting 67% 31% 2% 0% 0% implications Content is relevant to my 62% 34% 3% 1% 0% Andrew Kambugu, Uganda work Speakers’ performance 50% 40% 9% 1% 0%

Second-line therapies in RLS: Excellent Good Average Fair Poor the choices and evidence Topic is interesting 75% 22% 2% 1% 0% Nick Paton, Singapore Content is relevant to my 68% 26% 5% 1% 0% work Speakers’ performance 67% 26% 5% 1% 1%

Session: Prevention of mother-to child transmission (PMTCT)

Progress and challenges in Excellent Good Average Fair Poor PMTCT: the unfinished agenda Topic is interesting 77% 20% 3% 0% 0% Chewe Luo, Zambia Content is relevant to my 71% 23% 5% 1% 0% work Speakers’ performance 68% 28% 4% 0% 0%

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 11 PARTICIPANTS’ FEEDBACK

Satellite Symposium Gilead: Debate: Resolved that the continent of Africa is not yet ready to treat Hepatitis C

State of the Art on Hepatitis C Excellent Good Average Fair Poor Mark Nelson, UK Topic is interesting 78% 21% 1% 0% 0% Content is relevant to my 57% 29% 11% 3% 0% work Speakers’ performance 78% 20% 2% 0% 0%

Team affirming the motion Excellent Good Average Fair Poor Mark Nelson, UK Topic is interesting 74% 23% 3% 0% 0% Tapiwanashe Kujinga, Zimbabwe Content is relevant to my 55% 33% 8% 4% 0% work Speakers’ performance 59% 32% 9% 0% 0%

Team opposing the motion Excellent Good Average Fair Poor Kwasi Torpey, Nigeria Topic is interesting 51% 39% 7% 3% 0% Theobald Owusu-Ansah, Ghana Content is relevant to my 39% 39% 16% 6% 0% work Speakers’ performance 36% 40% 19% 4% 1%

HIV in Zimbabwe Excellent Good Average Fair Poor TsiTsi Apollo, Zimbabwe Topic is interesting 63% 34% 3% 0% 0% Content is relevant to my 67% 27% 6% 0% 0% work

Session: Official Opening Session

Progress in HIV prevention and Excellent Good Average Fair Poor treatment scale-up in sub- Topic is interesting 66% 32% 2% 0% 0% Saharan Africa Content is relevant to my 62% 34% 4% 0% 0% Michael Bartos, Australia work Speakers’ performance 64% 34% 2% 0% 0%

Joep Lange: Lessons for young Excellent Good Average Fair Poor and early career investigators Topic is interesting 76% 22% 2% 0% 0% Richard Koup, USA Content is relevant to my 65% 27% 5% 2% 1% work Speakers’ performance 71% 29% 0% 0% 0%

WEDNESDAY 6 MAY Session: HIV prevention, structural determinants, PrEP

Female-initiated HIV Prevention Excellent Good Average Fair Poor Methods: Past, Present and Topic is interesting 73% 26% 1% 0% 0% Future Content is relevant to my 55% 30% 13% 2% 0% Nyaradzo Mgodi, Zimbabwe work Speakers’ performance 59% 39% 2% 0% 0%

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 12 PARTICIPANTS’ FEEDBACK

Preventing HIV infection in Excellent Good Average Fair Poor young women – does money Topic is interesting 66% 33% 1% 0% 0% matter? Content is relevant to my 43% 42% 14% 1% 0% Sinead Delany-Moretlwe, work South Africa Speakers’ performance 54% 41% 5% 0% 0%

PrEP, learning from post-trial Excellent Good Average Fair Poor studies and demonstration Topic is interesting 57% 38% 5% 0% 0% projects Content is relevant to my 44% 38% 17% 1% 0% Kenneth Ngure, Kenya work Speakers’ performance 31% 46% 19% 4% 0%

Satellite symposium: Janssen, Pharmaceutical Companies of Johnson & Johnson “I Am Who I Am” - Teens living with HIV

A Teen’s story - living with HIV Excellent Good Average Fair Poor Young person living with HIV, Topic is interesting 88% 10% 2% 0% 0% Zimbabwe Content is relevant to my 81% 11% 8% 0% 0% work

Panel discussion: Excellent Good Average Fair Poor Support strategies for adolescents - What works? Topic is interesting 74% 24% 1% 1% 0% Content is relevant to my 66% 29% 4% 1% 0% Bahati Kasimonje, Zimbabwe work Speakers’ performance 60% 35% 3% 2% 0%

Nicola Willis, Zimbabwe

Rashida Ferrand, Zimbabwe

Managing ART in adolescents in Excellent Good Average Fair Poor nd rd 2 and 3 line Topic is interesting 81% 19% 0% 0% 0% Tariro Makadzange, Zimbabwe Content is relevant to my 84% 13% 3% 0% 0% work Speakers’ performance 76% 21% 2% 1% 0%

Integration of services and Excellent Good Average Fair Poor transition to adult care Topic is interesting 77% 19% 4% 0% 0% Margie Pascoe, Zimbabwe Content is relevant to my 72% 21% 6% 1% 0% work Speakers’ performance 73% 23% 3% 1% 0%

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 13 Session: Sex Work, Medication Adherence

The price of selling sex: HIV Excellent Good Average Fair Poor among female sex workers - Topic is interesting 49% 40% 9% 1% 1% Context and the public health Content is relevant to my 31% 34% 30% 4% 1% response work Frances Cowan, Zimbabwe; UK Speakers’ performance 25% 47% 24% 3% 1%

Medication Adherence: How Excellent Good Average Fair Poor much is enough? Topic is interesting 70% 24% 6% 0% 0% Terry Blaschke, USA Content is relevant to my 69% 19% 12% 0% 0% work Speakers’ performance 65% 27% 8% 0% 0%

Session: STI update and new WHO post-exposure prophylaxis guidelines

Latest findings from Zimbabwe’s Excellent Good Average Fair Poor ongoing STI etiology study Topic is interesting 72% 24% 4% 0% 0% Kees Rietmeijer, Zimbabwe Content is relevant to my 53% 38% 9% 0% 0% work Speakers’ performance 60% 36% 4% 0% 0%

Update on STI diagnostics, e.g., Excellent Good Average Fair Poor use of Gene-Xpert for GC/CT Topic is interesting 75% 21% 4% 0% 0% testing Content is relevant to my 63% 28% 6% 3% 0% Francis Ndowa, Zimbabwe work Speakers’ performance 71% 24% 5% 0% 0%

Implementing the new WHO Excellent Good Average Fair Poor post-exposure prophylaxis Topic is interesting 82% 17% 1% 0% 0% guidelines Content is relevant to my 74% 21% 5% 0% 0% François Venter, South Africa work Speakers’ performance 80% 19% 1% 0% 0%

Debate: PrEP is ready for prime time in Africa

Team affirming the motion Excellent Good Average Fair Poor Linda-Gail Bekker, South Africa Topic is interesting 80% 20% 0% 0% 0% Sinazo Peter, South Africa Content is relevant to my 70% 25% 3% 2% 0% work Speakers’ performance 70% 28% 2% 0% 0%

Team opposing the motion Excellent Good Average Fair Poor François Venter, South Africa Topic is interesting 82% 16% 0% 2% 0% Gaby Gomez, Netherlands Content is relevant to my 74% 21% 2% 3% 0% work Speakers’ performance 68% 28% 2% 0% 2%

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 14 THURSDAY 7 MAY Session: Antiretroviral therapy and viral load monitoring

Antiretroviral therapy update: Excellent Good Average Fair Poor impact of the 2014 WHO Topic is interesting 72% 25% 2% 0% 1% guidelines and improving the Content is relevant to my 63% 33% 2% 2% 0% cascade in resource-limited work settings Speakers’ performance 65% 30% 4% 1% 0% Nathan Ford, South Africa

Viral load monitoring: Excellent Good Average Fair Poor Challenges and innovation Topic is interesting 76% 18% 4% 2% 0% in laboratory diagnostic Content is relevant to my 67% 25% 5% 2% 1% implementation work Madisa Mine, Botswana Speakers’ performance 76% 21% 3% 0% 0%

Session: Early treatment and cure

Peadiatrics HIV disease Excellent Good Average Fair Poor Rashida Ferrand, Zimbabwe Topic is interesting 63% 32% 4% 1% 0% Content is relevant to my 54% 35% 8% 2% 1% work Tariro Makadzange, Zimbabwe Speakers’ performance 57% 37% 4% 0% 2%

Reservoirs and HIV Cure in Excellent Good Average Fair Poor Adults and Children: Insights Topic is interesting 59% 31% 8% 0% 2% and Challenges Content is relevant to my 41% 37% 13% 3% 6% Caroline Tiemessen, work South Africa Speakers’ performance 37% 49% 13% 0% 1%

Session: Voluntary Medical Male Circumcision

Research update Excellent Good Average Fair Poor Mufuta Tshimanga, Zimbabwe Topic is interesting 47% 42% 8% 2% 1% Content is relevant to my 37% 37% 21% 5% 0% work Speakers’ performance 35% 43% 16% 4% 2%

Programmatic progress and Excellent Good Average Fair Poor challenges: rollout and devices Topic is interesting 50% 41% 8% 1% 0% Karen Hatzold, Zimbabwe Content is relevant to my 31% 45% 20% 4% 0% work Speakers’ performance 41% 49% 8% 1% 1%

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 15 Roundtable: Update on HIV vaccine strategies and trials

HIV vaccine strategies Excellent Good Average Fair Poor Penny Moore, South Africa Topic is interesting 62% 30% 7% 1% 0% Content is relevant to my 42% 29% 21% 8% 0% work Speakers’ performance 55% 40% 5% 0% 0%

HIV vaccine trials: Lessons from Excellent Good Average Fair Poor efficacy trials and opportunities Topic is interesting 46% 41% 11% 2% 0% for future research Content is relevant to my 39% 29% 26% 5% 1% Hannah Kibuuka, Uganda work Speakers’ performance 36% 45% 17% 2% 0%

Session: Oral abstract presentations

Adherence assessment Excellent Good Average Fair Poor techniques in adolescents Topic is interesting 63% 34% 3% 0% 0% receiving protease inhibitor Content is relevant to my 59% 32% 8% 1% 0% based antiretroviral therapy in work a resource limited setting

Tinashe Mudzviti, Zimbabwe

Delays in confirming suspected Excellent Good Average Fair Poor treatment failure and in Topic is interesting 51% 37% 12% 0% 0% switching to second-line Content is relevant to my 48% 38% 13% 1% 0% antiretroviral therapy in Kenya work John Paul Otieno, Kenya

Pretreatment HIV drug Excellent Good Average Fair Poor resistance increases regimen Topic is interesting 48% 42% 10% 0% 0% Switch in Sub-Saharan Africa Content is relevant to my 45% 41% 14% 0% 0% Bernice Hoenderboom, the work Netherlands

Retention and long-term Excellent Good Average Fair Poor virologic outcomes in children Topic is interesting 53% 38% 7% 1% 1% and adolescents receiving HIV/ Content is relevant to my 48% 37% 14% 0% 1% ART care at a public sector work tertiary level hospital in Zimbabwe

Tariro Makadzange, Zambia

HIV infection among patients Excellent Good Average Fair Poor with sexually transmitted Topic is interesting 47% 40% 8% 3% 2% infections in Zimbabwe Content is relevant to my 45% 35% 18% 0% 2% Morblessing Mungati, Zimbabwe work

Early infant diagnosis data Excellent Good Average Fair Poor transmission system using Topic is interesting 48% 37% 11% 3% 1% mobile phones in Zimbabwe Content is relevant to my 49% 31% 17% 3% 0% Kenzy Chidawanyika, Zimbabwe work

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 16 Optimising uptake of PrePex Excellent Good Average Fair Poor circumcision among adult Topic is interesting 46% 34% 14% 5% 1% males through a mobile caravan Content is relevant to my 34% 39% 21% 4% 2% in Chitungwiza town, Zimbabwe work Pesanai Chatikobo, Zimbabwe

Delays in initiation of Excellent Good Average Fair Poor antiretroviral therapy among Topic is interesting 47% 44% 8% 1% 0% HIV-infected children in rural Content is relevant to my 41% 39% 18% 1% 1% Zambia work Francis Hamangaba

Roundtable: Treatment as Prevention (TaSP) studies: the challenge of CD4 count treatment eligibility changes in Africa and of PrEP trial and post-trial results. Perspectives from ongoing studies, study design changes, social science insights, challenges and opportunities

ANRS TasP in KwaZulu-Natal Excellent Good Average Fair Poor (South Africa) Topic is interesting 55% 36% 7% 1% 1% Joseph Larmarange, France Content is relevant to my 42% 41% 13% 2% 2% work Speakers’ performance 51% 35% 12% 2% 0%

MAX-ART (Swaziland) Excellent Good Average Fair Poor Sikhathele Mazibuko, Swaziland Topic is interesting 56% 38% 3% 3% 0% Content is relevant to my 44% 38% 14% 4% 0% work Speakers’ performance 45% 47% 8% 0% 0%

SEARCH (Uganda and Kenya) Excellent Good Average Fair Poor Moses Kamya, Uganda Topic is interesting 74% 24% 1% 1% 0% Content is relevant to my 61% 28% 11% 0% 0% work Speakers’ performance 74% 24% 1% 0% 1%

PopART (Zambia and South Excellent Good Average Fair Poor Africa) Topic is interesting 73% 24% 1% 1% 1% Kalpana Sabapathy, Zambia Content is relevant to my 52% 33% 12% 3% 0% work Speakers’ performance 66% 26% 7% 0% 1%

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 17 FRIDAY 8 MAY

Principles and reality of HIV Excellent Good Average Fair Poor drug resistance in sub- Saharan Topic is interesting 78% 20% 2% 0% 0% Africa Content is relevant to my 65% 30% 5% 0% 0% Doug Richman, USA work Speakers’ performance 66% 28% 6% 0% 0%

Long-term effectiveness of Excellent Good Average Fair Poor ART and HIVDR development in Topic is interesting 73% 24% 3% 0% 0% Africa Content is relevant to my 62% 35% 3% 0% 0% Kim Sigaloff, the Netherlands work Speakers’ performance 70% 29% 1% 0% 0%

Genesis of drug resistance in Excellent Good Average Fair Poor tuberculosis in South Africa Topic is interesting 78% 21% 1% 0% 0% Rob Warren, South Africa Content is relevant to my 64% 29% 6% 1% 0% work Speakers’ performance 69% 23% 8% 0% 0%

Antimalarial drug resistance in Excellent Good Average Fair Poor South Africa: Past, present and Topic is interesting 72% 22% 6% 0% 0% future! Content is relevant to my 60% 29% 8% 1% 2% Jaishree Raman, South Africa work Speakers’ performance 65% 26% 9% 0% 0%

Building laboratory networks Excellent Good Average Fair Poor and systems to prevent, detect Topic is interesting 54% 29% 17% 0% 0% and respond to antimicrobial Content is relevant to my 39% 35% 25% 1% 0% resistance in Africa work Trevor Peter, Botswana Speakers’ performance 54% 34% 11% 1% 0%

Approach to management of Excellent Good Average Fair Poor HIV – understanding the unmet Topic is interesting 87% 12% 0% 0% 1% medical needs with our current Content is relevant to my 78% 21% 0% 1% 0% use of antiretroviral drugs work François Venter, South Africa Speakers’ performance 83% 13% 3% 1% 0%

Has the current management of Excellent Good Average Fair Poor HIV reached a plateau or can we Topic is interesting 80% 20% 0% 0% 0% go further ? Content is relevant to my 75% 22% 3% 0% 0% Harold Kessler, USA work Speakers’ performance 68% 26% 3% 3% 0%

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 18 PARTICIPANTS’ FEEDBACK

TAKE HOME MESSAGES

What is the key take-home message you gained from the How will the take-home message affect your daily practice? lectures?

5 May 2015 Importance of viral load monitoring Increase VL Monitoring HCV challenge in Africa Pay attention to education nurses / MD’s Ebola Discuss results with patients

6 May 2015 Importance of PrEP in prevention Take more care on wishes of adolescents Involve adolescents / special care / adherence Improve counselling for adolescents

7 May 2015 Early start in children Multi disciplinary approach / team approach VMMC programs / Pre Pex Try to encourage students and colleagues to start doing something for their own people HIV vaccine: a long way to go

8 MAY 2015 Drug resistance is a big problem both in HIV and TB Test and treat approach Pay more attention to drug resistance

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 19 PARTICIPANTS’ FEEDBACK

MEETING OBJECTIVES

Strongly agree Agree Neutral Disagree Strongly disagree The workshop gathers international and 87% 13% 0% 0% 0% local experts involved in HIV from different disciplines in an interactive workshop setting The workshop translates the scientific data 65% 27% 7% 1% 0% into clinical guidance, applicable for daily management of HIV infected patients in resource-limited settings The workshop gives young researchers an 72% 24% 1% 3% 0% opportunity to present their data

IMPACT

Very much Agree Neutral Disagree Very much agree disagree Overall, attending the workshop has enhanced 67% 29% 4% 0% 0% my professional effectiveness As a clinician, I will improve my daily practice 69% 29% 2% 0% 0% as a result of attending this workshop

ABSTRACTS The meeting is abstract driven. It is well known as an excellent platform for young investigators to present their data. To ensure the quality, all submitted abstracts go through a blind, peer-reviewed process conducted by the members of the Organizing and Scientific Committees. The table below shows the abstract submission statistics from the past five years:

2011 2012 2013 2014 2015 Total number accepted abstracts 38 54 57 55 38 Oral presentations 12 12 18 13 8 Poster presentations 26 42 39 42 21 Poster discussions 9

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 20 PARTICIPANTS’ FEEDBACK

ORGANIZATION

Excellent Good Average Fair Poor Meeting Venue 63% 30% 7% 0% 0% Food & Beverage 52% 35% 11% 2% 0% Audiovisual 70% 29% 1% 0% 0% Information conference website 61% 27% 10% 1% 1% Online abstract submission process 57% 31% 8% 2% 2% Online registration process 56% 28% 9% 7% 0% Onsite logistics 69% 25% 5% 1% 0% Service level of conference secretariat 67% 29% 3% 1% 0%

GENERAL EVENT EXPERIENCE

Excellent Good Average Fair Poor Overall event experience 81% 19% 0% 0% 0% Opportunity of networking 65% 19% 16% 0% 0% Content of the workshop 81% 13% 6% 0% 0% Number of invited lectures versus abstracts 71% 23% 3% 3% 0% Time allocation for discussion 50% 23% 7% 13% 7% Time allocation per presentation 43% 36% 1% 3% 6% No commercial bias perceived 53% 34% 7% 3% 3% I would recommend this event to my peers 84% 13% 3% 0% 0% Plan to attend this event next time 79% 21% 0% 0% 0%

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 21 MEETING DEMOGRAPHICS

NUMBER OF REGISTRANTS 473 participants from 26 countries registered for the INTEREST Workshop in 2015. This year, like in previous years, the largest group is from the country where the event is held. Number of participants per country:

6 Botswana 16 Nigeria 2 Burkina Faso 1 Senegal 2 Ethiopia 1 Singapore 3 France 38 South Africa 1 Gambia 2 Swaziland 2 Germany 3 Switzerland 1 Ghana 17 The Netherlands 2 India 1 Turkey 8 Ivory Coast 9 Uganda 9 Kenya 15 United Kingdom 1 Mauritius 16 United States of America 7 Mozambique 15 Zambia 1 Namibia 294 Zimbabwe

PROFESSIONAL BACKGROUND Mainly employed by: Professional Background:

Marketing person Other University Other 1% 9% 16% Student 12% NGO 5% 24% Hospital 19% Clinician Researcher 60% 22% Industry Government 9% 23%

How did you know about this event: I was motivated to attend this meeting by:

other Returning participant VE website 3% Meeting 9% 18% free registration VE invitation flyer 15% objectives Word-of-mouth 2% 25% 23% Announcement experience societies previous editions 14% Scientific 6% program Invite from industry 30% Invite from faculty Flyer other meetings meet with my 16% members 1% colleagues 17% meeting location 17% 4%

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 22 PARTICIPANTS’ COMMENTS

SUGGESTIONS FOR IMPROVEMENT • More time needed for Q&A.

• Some presentations were too long

• Allocate more time for discussion

• More space for pediatric issues on behavior change issues

• Emphasize on paediatric issues and on what can be done in very low resources setting.

• Daily put up big posters with the program on the day just outside or in the venue.

CHALLENGES FACING IN DAILY PRACTICE • Viral load monitoring, stock out for second line treatment

• Availability of viral load monitoring, MDR medicines

• Mentorship back home is wanted

• The link between health service and community system strengthening is a huge gap in scaling up treatment success, adherence strategies and care/support systems at community level

• Stock outs of paediatric formulas

• We should focus on how to do things in lack of resources setting

FINAL REMARKS • Excellent conference

• It was my first experience at a health-related research conference, it was such an experience.

• Enjoyed this conference. Very informative and educative up to date events

• I need only say that I’m very thankfull for this opportunity

• Highly appreciated meeting

• Will want to attend similar workshop if resources permit

• The meeting was an eye opener to me

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 23 CONCLUSION

The commitment of the participants and their active participation in the discussions and Q&A sessions clearly show the need to continue this series of workshops.

Since its initiation in 2007, the INTEREST workshop remains the only focused Sub-Saharan meeting in the field. The program provides an excellent platform to exchange the medical information and new treatment results, and to discuss these with the experts active in the different disciplines. The cross-disciplinary sharing of information creates a unique opportunity to further improve the daily management of HIV-infected patients.

The Organizing Committee is pleased with the results of the 9th International Workshop on HIV Treatment, Pathogenesis and Prevention Research in Resource Limited Settings.

The workshop clearly meets a need for international interchange on this important topic. Given the success of this past meeting and the highly positive results of the evaluation, the organizers are looking forward to a new edition of the workshop 3-6 May 2016 in Cameroon.

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 24 LIST OF PARTICIPANTS

Last name, name Institute Country A Adejumo, Olurotimi University College Hospital Nigeria Agogo, Emmanuel National Agency for Control of AIDS Nigeria Ahimon, Herodias AbbVie Ivory Coast Aly, Fatima EKN Mozambique Amani, Anzian CEPREF Medical Centre Ivory Coast Ameer, Saranna University Of Zimbabwe Zimbabwe António, Simone Faculdade de Ciências de Saúde- Universidade Católica Mozambique de Moz Anyaike, Chukwuma National Agency for Control of AIDS Nigeria Anyango, Ruth Moi University Kenya Apollo, Tsitsi Ministry of Health & Child Care Zimbabwe B Ball, Scott Toucan Events, for Gilead United Kingdom Banda, Sandra Mylan Laboratories Limited Zimbabwe Banda, Tom Ministry of Health - Global Fund Zimbabwe Barnes, Peter Janssen United Kingdom Bartos, Michael UNAIDS Zimbabwe Bekker, Linda-Gail Desmond Tutu HIV Foundation South Africa Bepe, Tafadzwa Ministry of Health & Child Care Zimbabwe Bhagat, Balvant Union Avenue Medical Clinic Zimbabwe Binha, Lennon The People's Voice Zimbabwe Bissagnene, Emmanuel University and Medical Centre Treichville Ivory Coast Blaschke, Terrence Bill & Melinda Gates Foundation USA Boerma, Ragna AIGHD Foundation The Netherlands Bogoshi, Mampedi Gilead UK Bonde, Rutendo Zimbabwe Association of Doctors for Human Rights Zimbabwe Borok, Margaret UZ college of Health Science Zimbabwe Bosaakane, Motlamedi Nyangabgwe Referral Hospital Botswana Boucher, Charles Erasmus Medical Center The Netherlands Bouic, Anja Harare Central Hospital Zimbabwe Brebner, Nicola Sharing Health Empowerment Zimbabwe Bwakura, Tapiwa Zimbabwe Bwakura-Dangarembizi, University of Zimbabwe Zimbabwe Mutsawashe Byakika-Kibwika, Pauline Makerere University College of Health Sciences Uganda C Celia, Moffat Joel Matyanga Harare Institute of Technology Zimbabwe Chadambuka, Addmore Elizabeth Glaser Pediatric AIDS Foundation Zimbabwe Chakanyuka, Chilembo WHO Zimbabwe Chakanyuka, Ruvimbo The Herald Zimbabwe Chatikobo, Pesanai Zimbabwe Community Health Intervention Project Zimbabwe Chawana, Tariro University Of Zimbabwe Zimbabwe

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 25 Chemhuru, Milton Ministry of Health & Child Care Zimbabwe Chiambiro, Jacqueline Mylan Laboratories Limited Zimbabwe Chibamu, Anna Flame News Zimbabwe Chidawanyika, Henry RTI International Zimbabwe Chideme, Memory EGPAF Zimbabwe Chigaramasimbe, Tafadzwa Kadoma General Hospital Zimbabwe Chikosi, Ruth Zimbabwe Chikwava, Liliani Ministry of Health & Child Care Zimbabwe Chimbetete, Cleophas Newlands Clinic Zimbabwe Chimbetete, Kenneth CIMAS clinic Zimbabwe Chinganga, Evans Zimbabwe Chipamaunga, Tsungai University of Zimbabwe Zimbabwe Chirenda, Joconiah University of Zimbabwe Zimbabwe Chisipo, Jabalani Chaminuka News Zimbabwe Chivedzo, Josiah Dimbo The Afro News Zimbabwe Chiwanga, Michael Chitungwiza Central Hospital Zimbabwe Chiware, J.Z. Ministry of Health Zimbabwe Choto, Regis Chikomborero Ministry of Health and Child Care Zimbabwe Choudhry, Altaf Cimas Medical Aid Society Healthcare Services Division Zimbabwe Claessen, Frans Universidade Catolica de Mocambique Mocambique Collins, Erin GP surgery Zimbabwe Conradie, Francesca Right to Care South Africa Coots, Dianne General Practice Zimbabwe Corrigan, Bethany Elizabeth Glaser Pediatric AIDS Foundation USA Cowan, Frances CeSHHAR Zimbabwe D Dakshina, Suba Biomedical and Research Training Institute Zimbabwe Dandadzi, Terence Ministry of Health & Child Care Zimbabwe Dauya, Ethel Biomedical Research and training Institute Zimbabwe Davies, Rosslyn Dr. R.C.Davies General Practice Zimbabwe Delany-Moretlwe, Sinéad University of the Witwatersrand South Africa Dexter, Tsopotsa Corporate 24 Zimbabwe Dhlakama, Colin PSMI Zimbabwe Dhliwayo, Malvern Kariba District Hospital Zimbabwe Dhliwayo, Rumbidzai MSF/OCA Zimbabwe Dube, Freeman National aids Council Zimbabwe Dube, Fungisai Citizens Health Watch Zimbabwe E Ekong, Ernest Edem Institute of Human Virology Nigeria Enegela, Joseph Elaikwu Pro Health International Nigeria Essen, Nyomudim Effiong Gariki Specialist Hospital Nigeria F Ferrand, Rashida London School of Hygiene & Tropical Medicine United Kingdom

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 26 Ferrari, Guido Duke University Medical Center USA Ford, Nathan World Health Organization Switzerland Frank, George Dr G Frank Surgery Zimbabwe Franson, Masiye Chinhosi Provincial Hospital Zimbabwe Funsani, Peter Ministry of Health Zambia G Gainsford, Shirley Stephanie Moss Solutions South Africa Gambahaya, Ellise Parirenyatwa Group of Hospitals Zimbabwe Gaolathe, Tendani Botwana Harvard Partnership Botswana Gapu, Paradzai Parirenyatwa Group of Hospitals Zimbabwe Glaue, Finnja T.O.M. Life Science Consulting Germany Glavintcheva, Iskra Zimbabwe Gomez, Gabriela AIGHD Foundation The Netherlands Gonese, Gloria GP surgery Zimbabwe Gonese, Elizabeth Centers for Disease Control and Prevention Zimbabwe Gorejena, Pamela University of Zimbabwe Zimbabwe Goudjo, Adnon FEI-PASST/AFD, Ministere de la Sante Publique Ivory Coast Govha, Emmanuel Gaune South Hospital Zimbabwe Govindasamy, Santoshni GSK South Africa Gumbo, Gwendoline Pangaea Zimbabwe aids Trust Zimbabwe Gurupira, Wilfred UZ-UCSF Zimbabwe Gutu, Linus Ministry of Health & Child Care Zimbabwe Gwavava, Emily Population Services International Zimbabwe Zimbabwe H Hakata, Michelle Herald House Zimbabwe Hakim, James University of Zimbabwe Zimbabwe Hamada, Matt AbbVie USA Hamangaba, Francis Macha Research Trust Zambia Hankins, Catherine Amsterdam Institute for Global Health and Development The Netherlands Haq, Yameen GP surgery Zimbabwe Harawara Ruth Zimbabwe Hatzold, Karen Population Services International Zimbabwe Herbert, Joseph Toucan Events, for Gilead United Kingdom Hermans, Lucas University Medical Center Utrecht The Netherlands Hoenderboom, Bernice AIGHD Foundation The Netherlands Hove, Joseph Zimbabwe Hunter, Brian Save the Children Zimbabwe J Jakanani, Tapiwa University of Zimbabwe College of Health Sciences Zimbabwe Jasi, Spencer Weekly Mirror Zimbabwe Jenkins, Kenneth Dr Kenneth Jenkins Zimbabwe Jima, Simbarashe University of zimbabwe Zimbabwe Jongwe, Richard Pulse Pharma Zimbabwe

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 27 K Kabalan, Rehema Janssen United Kingdom Kaiser, Reinhard World Health Organization Zimbabwe Kambole, Charles AbbVie South Africa Kambugu, Andrew Infectious Diseases Institute Uganda Kamenova, Kamelia SolidarMed Zimbabwe Kamya, Moses Rakai District Local Government Uganda Kangwende, Rugare Zimbabwe Kanyemba, Alice Ministry of Health and Child Care, Zimbabwe Zimbabwe Kapenzi, Rebecca Africa Women Filmmakers Trust Zimbabwe Kariuki, Ephantus Aspen Pharma South Africa Kasimonje, Bahati Newlands Clinic Zimbabwe Kassi, Ndouba Alain Charles Chu De Treichville Ivory Coast Katabira, Elly Rakai District Local Government Uganda Katayamoyo, Patrick FHI 360 - ZPCT II Zambia Katsidzira, Agnes Harare Central Hospital Zimbabwe Kauroo, Arshad GSK Mauritius Kessler, Harold ViiV Healthcare USA Khabo, Bekezela Bobby Ministry of Health & Child Care Zimbabwe Kibuuka, Hannah Rakai District Local Government Uganda Kilmarx, Peter CDC USA Kone-Koffi, Fatoumata CHU Treichville Ivory Coast Koup, Richard Vaccine Research Center NIAID, NIH USA Kroeze, Stefanie Amsterdam Institute for Global Health and Development The Netherlands Kubheka, Sibongile GSK South Africa Kudakwashe, Mukwe Clara MOH Zimbabwe Kujinga, Tapiwanashe Pan-African Treatment Access Movement Zimbabwe Kumar, Prabhat Pulse Pharma Zimbabwe Kumaraswamy, Ekhambram Mylan Laboratories Limited India Kunzekwenyika, Cordelia Newlands Clinic Zimbabwe Kurauone, W. Ministry of Health & Child Care Zimbabwe Dr Kuretu Ministry of Health and Child Care, Zimbabwe Zimbabwe Kutadza, Tariro Development AId from People To People Zimbabwe Kwaramba, Benedicta Newlands Clinic Zimbabwe Kwiri, Shelton Ministry of Health & Child Care Zimbabwe L Landman, Ingrid Zimbabwe AIDS Care Foundation Zimbabwe Landman, Matthew Sharing Health Empowerment Zimbabwe Lange, Max The Netherlands Larmarange, Joseph French Research Institute for Development France Letsatsi-Modise, Virginia Princess Marina Hospital Botswana Levin, Leon Right to Care South Africa Lowden-Stoole, Gayle Zimbabwe

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 28 Lowe, Sara University of Zimbabwe Zimbabwe Lukiana, Tuna ViiV Healthcare France Lunga, Rebecca Shekena Helath Centre Zimbabwe Luo, Chewe UNICEF USA Luo, Robert Roche Molecular Systems USA M Mabaso, Thembe Aspen Pharma South Africa Maboreke, Nyasha Zimbabwe Mabuku, Japhet Elizabeth Glaser Pediatric AIDS Foundation Zimbabwe Macheri, Farai Parirenyatwa Group of Hospitals Zimbabwe Machiridza, Tendai University of Zimbabwe Zimbabwe Macquire, Frances Rural Clinic Mouore Zimbabwe Madihlaba, Tshepiso AbbVie South Africa Maenzanise, Stewart SC Healthcare Solutions Zimbabwe Maenzanise, Vallarie Harare Hospital Zimbabwe Mafundikwa, Ish UNAIDS Zimbabwe Magomnedze, Sibonokuhle PAZ Zimbabwe Magumise, Bornfree Davis Granite Zimbabwe Mahomva, Agnes Zimbabwe Medical Association Zimbabwe Makaba, Imelda Pangaea Zimbabwe aids Trust Zimbabwe Makadzange, Tariro Ragon Institute of MGH, MIT and Harvard USA Makalele, Patrick FH360 ZPCT II B Zambia Makaure, Sif ZICHIRE Zimbabwe Makhanya, Phindile AbbVie South Africa Makokoba, Klatmore Flame News Zimbabwe Makoni, Nela Koleva Zimbabwe Makuchete, Memory University of Zimbabwe College of Health Sciences Zimbabwe Malan, Emile GSK South Africa Mamvura, Rutendo Harare Central Hospital Zimbabwe Mandamombe, Tatenda Ministry of Health & Child Care Zimbabwe Mandima, Patricia UZ-UCSF Zimbabwe Mandima, Patricia Parirenyatwa Hospital Zimbabwe Mangwiro, George Smart Dibetic and Health News Zimbabwe ManoMano, Precious ZIFM Stereo Zimbabwe Manson, Karen Janssen United Kingdom Manyeruke, Felix university of zimbabwe Zimbabwe Mapfumo, Rejoice Harare Central Hospital Zimbabwe Maphosa, Talent St Joseph Mission Hospital Zimbabwe Maphosa, Treretse Ministry of Health & Child Care Zimbabwe Mapuronga, Dwayne Zulu and Partners Zimbabwe Maraj De Villiers, Usheema Janssen Global Access Programmes, Virology South Africa Maramba, Patience Julia University of Zimbabwe College of Health Sciences Zimbabwe Marape, G. Ministry of Health & Child Care Zimbabwe

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 29 Marimbe-Nyatsambo, Pamela UZ-UCSF Zimbabwe Grace Mariwa, Fadwick Kudzai Ministry of Health & Child Care Zimbabwe Maseko, Sithembiso Delta Beverages Zimbabwe Masendeke, Absolom RTI International Zimbabwe Mashaah, Thokozile University of Zimbabwe Zimbabwe Mashaba, Oteng AbbVie South Africa Mashoko, Chamunorwa Sankofa Zimbabwe Masimbe, Banjamin Delta Corporation Zimbabwe Masitano, Chilembo Ministry of Health Zimbabwe Masuka, Nuasha Ministry of Health & Child Care Zimbabwe Matakala, Hellen Macha Research Trust Zambia Matewa, Chidu Africa Women Filmmakers Trust Zimbabwe Matheri, Joseck AbbVie South Africa Matimba, Maxwell Evaristo University Of Zimbabwe Zimbabwe Matongo, Ishmael D. Eastville Medical Clinic Zimbabwe Matshaba, Mogomotsi Sandy Baylor/Botswana Center Botswana Matsvimbo, Paul MOH Zimbabwe Maunga, Dr Ministry of Health & Child Care Zimbabwe Maunze, Chenal Ministry of Health & Child Care Zimbabwe Mavetera, Justice Parirenyatwa Group of Hospitals Zimbabwe Mavhu, Webster CeSHHAR Zimbabwe Zimbabwe Mawere, Walter UNAIDS Zimbabwe Mawere, Mavis Premier Service Medical Investments Zimbabwe Mawire, Wallace international aids Alliance Zimbabwe Mazibuko, Sikhathele Ministry of Health Swaziland Mazvarirashe, Mabugu Wisdom Institute International Zimbabwe Zimbabwe Mbengeranwa, Lovemore Health Service Board Zimbabwe Mbengeranwa, Tapiwa UZ-UCSF Zimbabwe Mbengo, Faith Elizabeth Glaser Pediatric AIDS Foundation Zimbabwe Mbizvo, Elizabeth MOHCW Zimbabwe Mbizvo, Mike University of Ziombabwe Zimbabwe Mburu, Margaret Kenya Medical Research Institute Kenya McHugh, Grace Biomedical Research and training Institute Zimbabwe Mertenskoetter, Thomas T.O.M. Life Science Consulting Germany Mgodi, Nyaradzo Mavis University of Zimbabwe-UCSF Zimbabwe Mhlanga, Trudy MOH Zimbabwe Mine, Madisa Botswana-Harvard AIDS Institute Botswana RungaMisheck Lab Assist Zimbabwe Zimbabwe Miti, Anna AVAC Zimbabwe Miti, Joel Tutu Medical Access Uganda Mkanganwi, Mucha Pulse Pharma Zimbabwe Mkwanazi, Dumi Gilead South Africa

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 30 Mlambo, Charmaine Khudzie Clinton Health Access Initiave Swaziland Mlilo, Thulani Ministry of Health & Child Care Zimbabwe Modongo, Chawangwa Gaborone Children's Care Clinic Botswana Moga, Tafara Elizabeth Glaser Pediatric AIDS Foundation Zimbabwe Zimbabwe Monteiro, Mauro UCM/FCS Mozambique Moore, Penny National Institute for Communicable Diseases South Africa Moorhouse, Michelle Wits RHI South Africa Morin, Sebastien International AIDS Society Switzerland Mosia, Dudu Aspen Pharma South Africa Mothobi, Nomvuyo Parirenyatwa Group of Hospitals Zimbabwe Mphaya, Joyce UNICEF Zimbabwe Dr Msau Ministry of Health and Child Care, Zimbabwe Zimbabwe Msaulloyd Ministry of Health Zimbabwe Muchedzi, Auxilia Elizabeth Glaser Pediatric AIDS Foundation Zimbabwe Zimbabwe Muchedzi, Charles Warren Park Medical Centre Zimbabwe Muchemwa, Mollie Flame News Zimbabwe Muchenje, Ester Elizabeth Glaser Pediatric AIDS Foundation Zimbabwe Muchongwe, Fact GP surgery Zimbabwe Mudzviti, Tinashe University of Zimbabwe Zimbabwe Mugo, Joshua AbbVie South Africa Mujuru, Peter EGPAF Zimbabwe Mukanyimi, Bosco FHI360 Zambia Mukungunu, Solomon Ministry of Health & Child Care Zimbabwe Mukungunugwa, Solomon Ministry of Health &Child Care Zimbabwe Mukuya, Obed Chitungwiza City Health Zimbabwe Mulenga, Lloyd University Teaching Hospital Zambia Mulinga, Albert MOH Zimbabwe Mungwadzi, Godfrey University Of Zimbabwe Zimbabwe Munhenga, Enock Artist Zimbabwe Munjoma, Marshall University of Zimbabwe-UCSF Zimbabwe Munyaradze, Tinashe MOH Zimbabwe Munyoro, Chivako Nehanda Guardian News Zimbabwe Mupepe, Brian Cimas Medical Aid Society Healthcare Services Division Zimbabwe Mupungani, Crispen National Institute of Health research Zimbabwe Murandu, Mildrate Elizabeth Glaser Pediatric AIDS Foundation Zimbabwe Muriira (Mwiti), William GSK Kenya Murimwa, Tonderayi UNICEF Zimbabwe Murinye, Mercy Ministry of Health & Child Care Zimbabwe Murtezaoglu, Aysan Gilead Turkey Murungu, Joseph Ministry of Health Zimbabwe Musarandega, Reuben Elizabeth Glaser Pediatric AIDS Foundation Zimbabwe Musemwa, Caroline University of Zimbabwe College of Health Sciences Zimbabwe Muserere, Claudios University Of Zimbabwe Clinical Research Centre Zimbabwe

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 31 Musesengwa, Rosemary Medical Research Council Of Zimbabwe Zimbabwe Mushavi, Angela Ministry of Health Zimbabwe Musikia, Taurayi Portia Flame News Zimbabwe Musira, Patrick PMAN / Media Zimbabwe Musiya, Dr Ministry of Health & Child Care Zimbabwe Musodza, Yeukai UZ Clincal Research centre Zimbabwe Musoro, Godfrey University of Zimbabwe UZCRC Zimbabwe Mutede, Blessing Elizabeth Glaser Pediatric AIDS Foundation Zimbabwe Mutizira, G. Ministry of Health & Child Care Zimbabwe Mutugi M’Muriithi, Jamlick FHI360 Kenya Muzambi, Margaret University of Zimbabwe Clinical ResearchCentre Zimbabwe Muzondiona, Adonija National AIDS Council of Zimbabwe Zimbabwe Mwale, Catherine Ukwimi FHI36 / ZPCT II B Zimbabwe Mwango, Albert Ministry of Health Zambia Mweemba, Aggrey University Teaching Hospital Zambia Mwila, Ernest Churches Health Association of Zambia Zambia Mzingwane, Mayibongwe National University of Science and Technology Zimbabwe N Namagala Mutyaba, Elizabeth Ministry of Health Uganda Nathoo, Kusum University of Zimbabwe Zimbabwe Ncomanzi, Tembinkozi Elizabeth Glaser Pediatric AIDS Foundation Zimbabwe Ncube, Gertrude Ministry of Health and Child Care, Zimbabwe Zimbabwe Ndlovu, Sithoberile Probe Market Research Zimbabwe Ndondo, Humphrey Sexual Rights centre Zimbabwe Ndongeni, Verna Roche Products South Africa Ndowa, Francis World Health Organisation (WHO) Switzerland Nelson, Leigh Gilead / Toucan United Kingdom Nelson, Mark Chelsea and Westminster Hospital United Kingdom Ngure, Kenneth Jomo Kenyatta University of Agriculture and Technology Kenya Nhando, Nehemiah UZ - UCSF Zimbabwe Nhende, Tonderai Ministry of Health Chegutu Zimbabwe Nigro, Luciano Luisa Guidotti Hospital Zimbabwe Nijboer, Marloes Amsterdam Institute for Global Health and Development The Netherlands Njoni, Bruce Albinos Trust of Zimbabwe Zimbabwe Nkomo, Briljant Ministry of Health & Child Care Zimbabwe Nnadozie Ekwolugo, Ifeoma AbbVie Nigeria Constance Nyagura, Farai Zimbabwe Republic Police Zimbabwe Nyagura, Tendai Ministry of Health and Child Care Zimbabwe Nyahwema, Abgail CIMAS clinic Zimbabwe Nyambiya, Tendai Zichire Zimbabwe Nyamukachi, Charles University of Zimbabwe Zimbabwe Nyamundaya, Tichaona Elizabeth Glaser Pediatric AIDS Foundation Zimbabwe Zimbabwe

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 32 Nyatanga-Pfupa, Tadiwa National AIDS Council Zimbabwe Nyathi, P. Ministry of Health & Child Care Zimbabwe Nyatsanga, Munyakadzi Pharmaceutical and Chemical Distributions Zimbabwe Nyika, Howard Ministry of Health and Child Care, Zimbabwe Zimbabwe Nyika, Ponesai RTI International Zimbabwe Nyirenda, Hellen Malcolm Watsob Children Hospital Zambia Nzuwa, Rutendo Ministry of Health Zimbabwe O Obaitua, Itua Joseph Achieving Health Nigeria Initiative Nigeria Ofondu, Eugenia Ogugua Federal Medical Center Owerri Nigeria Olutola, Ayodotun Oladeji Centre for Clinical Care and Clinical Research Nigeria Omonge, Enoch University Of Nairobi Kenya Ondoa, Pascale AIGHD Foundation The Netherlands Oraka, Chinedu Nnamdi Azikiwe University Teaching Hospital Nigeria Otieno, John Paul Kenya Medical Research Institute Kenya Otohabru Babajiru, Bravo National Agency for Control of AIDS Nigeria Owhonda, Golden Chukwuemeka State AIDS/STI Control Nigeria Owusu, Theobald Ghana P Pascoe, Margie Zimbabwe Pasi, Christopher Zimbabwe Paton, Nick National University of Singapore Singapore Peter, Sinazo Desmond Tutu HIV Foundation South Africa Pfeiffer, Annett Universidade Catolica de Mocambique Mozambique Pintainho, Abilito UCM/FCS Mozambique Posthumus-Plantinga, Alice Virology Education The Netherlands Purdy, Sheldon Gilead Sciences South Africa R Raman, Jaishree National Institute for Communicable Diseases South Africa Reeves, Ally Ashfield Meetings and Events United Kingdom Regede, Clarissa Zimbabwe Lawyers for Human Rights Zimbabwe Reid, Andrew UZ-CRC Zimbabwe Remigereau-Beauvais, Laurianne Laboratoire GSK France Richman, Douglas UCSD USA Rietmeijer, Kees Univerisity of Colorado Denver USA Rinke de Wit, Tobias Pharmaccess Foundation The Netherlands Robertson, Graeme Gilead Sciences Europe United Kingdom Rothwell, Simon Dr Rothwell Zimbabwe Roy, Niladrisekhar Mylan Laboratories Limited India Ruffell, Carol Janssen Global Access Programmes, Virology South Africa Runga, Pedzisayi Lab Assist Zimbabwe Zimbabwe S Sabapathy, Kalpana London School of Hygiene & Tropical Medicine United Kingdom

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 33 Sadomba, Hillary Tapiwa Ministry of Health & Child Care Zimbabwe Salamon, Daniel Toucan Events, for Gilead United Kingdom Samaneka, Wadzanai University Of Zimbabwe Zimbabwe Sandwith, Nicole Scholar Zimbabwe Shamu, Tendai RTI International Zimbabwe Shamu, Tinei Newlands Clinic Zimbabwe Shawarira-Bote, Sandra Newlands Clinic Zimbabwe Shelton, Sibanda MOHCC - Misabe Mission Zimbabwe Shumba, Prosper National Institure of Health Research Zimbabwe Sibanda, Euphemia Centre for Sexual Health & HIV/AIDS Research Zimbabwe (CeSHHAR Zimbabwe) Sickle, Eugene RHRU, University of Witwatersrand South Africa Sigaloff, Kim Amsterdam Medisch Centrum (AMC) The Netherlands Sinkamba, Elias Ministry of Health / Global Fund PMV Zambia Sirewu, Caroline National AIDS Council of Zimbabwe Zimbabwe Sithole, N. Ministry of Health & Child Care Zimbabwe Sixpence, Paul Centre Stage Media Arts Foundation Zimbabwe Siyingwa, Rodgers Ministry of Health Zimbabwe Smith, Wendy Wordsmiths International Ltd. (Medical writer) United Kingdom Sola, Dr Ministry of Health & Child Care Zimbabwe Sow, Papa Salif Dakar University Teaching Hospital Senegal Spieker, Nicole Pharmaccess Foundation the Netherlands Sullivan, Erin AbbVie USA Svowa, Allen MOHLL (Filabusi Hospital) Zimbabwe T Takarinda, Kudakwashe Ministry of Health & Child Care Zimbabwe Tapesana, Stanley Ministry of Health & Child care Zimbabwe Taramusi, Isaac National AIDS Council of Zimbabwe Zimbabwe Tawanda, Mapuranga MOH Zimbabwe Tembani Munyandu, Noleen UZ college f Health Zimbabwe Tembani, Norrin Script Pharmacy Zimbabwe Tembinkosi, Ncomanzi Egpaf Zimbabwe Tembo, Doreen University of Essex United Kingdom Thomas, Bruce Bill and Melinda Gates Foundation USA Tiemessen, Caroline University of the Witwatersrand South Africa Tlou, Sheila UNAIDS Zambia Tokonyai, Angelar Harare Central Hospital Zimbabwe Torpey, Kwasi FHI 360 - ZPCT II Zambia Trinchan, F. Ministry of Health & Child Care Zimbabwe Trivangani, Tafadzwa Zimbabwe Tshimanga, Mufata University of Zimbabwe Zimbabwe U Uche, Ralph-Opara FHI360 Nigeria

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 34 Ushewokunze, Ndaizivei General Practice Zimbabwe Uzande, Charles Ministry of Health & Child Care Zimbabwe V van de Vijver, David Erasmus Medical Center The Netherlands van Delft, Yvon Janssen-Cilag B.V. The Netherlands Van der Westhuizen, Olga GSK South Africa van Dijk, Janneke Parirenyatwa Group of Hospitals Zimbabwe Van Swaaij, Leny Universidade Catolica de Mocambique Mozambique van Wyk, Jean AbbVie USA Vengere, Calvin Harare City Council Zimbabwe Venter, François University of the Witwatersrand South Africa Vere, Norah Sukutayi Centers for Disease Control and Prevention / Zimbabwe Zimbabwe Veronica, Stanley Davis Granite Zimbabwe Vhembo, Tichaona University of Zimbabwe-UCSF Zimbabwe Vintges, marga GGD Rotterdam Rijnmond the Netherlands W Warambwa, Colin U.Z. Clinical Research Center Zimbabwe Warren, Rob Stellenbosch University South Africa Washaya, George Harare Central Hospital Zimbabwe Webb, Karen Organisation for Public Health Interventions and Zimbabwe Development (OPHID) Wellington, Maureen Newlands Clinic Zimbabwe Willis, Nicola Zimbabwe AIDS Care Foundation Zimbabwe Y Yepowa, Mulolo John Kitwe Central Hospital Zambia Z Zavahir, Shabnam Roche Products (Pty) Ltd South Africa Zhakata, Gertrude Ministry of Health & Child Care Zimbabwe Zichawo, Shelton Nash Union Avenue Medical Clinic Zimbabwe Zinyemba, Caroline Elizabeth Glaser Pediatric AIDS Foundation Zimbabwe Zimbabwe Zozhou, Simukai Ministry of Health and Child Care, Zimbabwe Zimbabwe Zvegona-Chigariro, Tavonga Elizabeth Glaser Pediatric AIDS Foundation Zimbabwe

EVALUATION REPORT 9th INTEREST workshop 5 - 8 May 2015, Harare, Zimbabwe 35